Maria Regoni, Letizia Zanetti, Martina Sevegnani, Chiara Domenicale, Stefano Magnabosco, Jyoti C Patel, Megan K Fernandes, Ryan M Feeley, Elena Monzani, Cecilia Mini, Stefano Comai, Laura Cherchi, Danilo De Gregorio, Isabella Soliman, Fabio Ruto, Laura Croci, Giacomo Consalez, Simona Rodighiero, Andrea Ciammola, Flavia Valtorta, Michele Morari, Giovanni Piccoli, Margaret E Rice, Jenny Sassone
{"title":"PrknR275W幼年帕金森病小鼠模型中的多巴胺神经元功能障碍和缺失。","authors":"Maria Regoni, Letizia Zanetti, Martina Sevegnani, Chiara Domenicale, Stefano Magnabosco, Jyoti C Patel, Megan K Fernandes, Ryan M Feeley, Elena Monzani, Cecilia Mini, Stefano Comai, Laura Cherchi, Danilo De Gregorio, Isabella Soliman, Fabio Ruto, Laura Croci, Giacomo Consalez, Simona Rodighiero, Andrea Ciammola, Flavia Valtorta, Michele Morari, Giovanni Piccoli, Margaret E Rice, Jenny Sassone","doi":"10.1093/brain/awae276","DOIUrl":null,"url":null,"abstract":"<p><p>Mutations in the PRKN gene encoding the protein parkin cause autosomal recessive juvenile parkinsonism (ARJP). Harnessing this mutation to create an early-onset Parkinson's disease mouse model would provide a unique opportunity to clarify the mechanisms involved in the neurodegenerative process and lay the groundwork for the development of neuroprotective strategies. To this end, we created a knock-in mouse carrying the homozygous PrknR275W mutation, which is the missense mutation with the highest allelic frequency in PRKN patients. We evaluated the anatomical and functional integrity of the nigrostriatal dopamine (DA) pathway, as well as motor behaviour in PrknR275W mice of both sexes. We report here that PrknR275W mice show early DA neuron dysfunction, age-dependent loss of DA neurons in the substantia nigra, decreased DA content and stimulus-evoked DA release in the striatum, and progressive motor impairment. Together, these data show that the PrknR275W mouse recapitulates key features of ARJP. Thus, these studies fill a critical need in the field by introducing a promising new Parkinson's disease model in which to study causative mechanisms of the disease and test therapeutic strategies.</p>","PeriodicalId":9063,"journal":{"name":"Brain","volume":null,"pages":null},"PeriodicalIF":10.6000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Dopamine neuron dysfunction and loss in the PrknR275W mouse model of juvenile parkinsonism.\",\"authors\":\"Maria Regoni, Letizia Zanetti, Martina Sevegnani, Chiara Domenicale, Stefano Magnabosco, Jyoti C Patel, Megan K Fernandes, Ryan M Feeley, Elena Monzani, Cecilia Mini, Stefano Comai, Laura Cherchi, Danilo De Gregorio, Isabella Soliman, Fabio Ruto, Laura Croci, Giacomo Consalez, Simona Rodighiero, Andrea Ciammola, Flavia Valtorta, Michele Morari, Giovanni Piccoli, Margaret E Rice, Jenny Sassone\",\"doi\":\"10.1093/brain/awae276\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Mutations in the PRKN gene encoding the protein parkin cause autosomal recessive juvenile parkinsonism (ARJP). Harnessing this mutation to create an early-onset Parkinson's disease mouse model would provide a unique opportunity to clarify the mechanisms involved in the neurodegenerative process and lay the groundwork for the development of neuroprotective strategies. To this end, we created a knock-in mouse carrying the homozygous PrknR275W mutation, which is the missense mutation with the highest allelic frequency in PRKN patients. We evaluated the anatomical and functional integrity of the nigrostriatal dopamine (DA) pathway, as well as motor behaviour in PrknR275W mice of both sexes. We report here that PrknR275W mice show early DA neuron dysfunction, age-dependent loss of DA neurons in the substantia nigra, decreased DA content and stimulus-evoked DA release in the striatum, and progressive motor impairment. Together, these data show that the PrknR275W mouse recapitulates key features of ARJP. Thus, these studies fill a critical need in the field by introducing a promising new Parkinson's disease model in which to study causative mechanisms of the disease and test therapeutic strategies.</p>\",\"PeriodicalId\":9063,\"journal\":{\"name\":\"Brain\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":10.6000,\"publicationDate\":\"2024-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Brain\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1093/brain/awae276\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Brain","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/brain/awae276","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
摘要
编码蛋白 parkin 的 PRKN 基因突变会导致常染色体隐性幼年帕金森病(ARJP)。利用这种突变创建早发帕金森病小鼠模型将为阐明神经退行性过程的相关机制提供一个独特的机会,并为开发神经保护策略奠定基础。为此,我们创建了一种携带同源 PrknR275W 突变的基因敲入小鼠,这是 PRKN 患者中等位基因频率最高的错义突变。我们评估了黑质多巴胺(DA)通路的解剖和功能完整性,以及 PrknR275W 雌雄小鼠的运动行为。我们在此报告,PrknR275W 小鼠表现出早期 DA 神经元功能障碍、黑质中 DA 神经元的年龄依赖性缺失、纹状体中 DA 含量和刺激诱发的 DA 释放减少以及进行性运动障碍。这些数据共同表明,PrknR275W 小鼠再现了 ARJP 的关键特征。因此,这些研究填补了这一领域的关键需求,引入了一种很有前景的新帕金森病模型,用于研究该病的致病机制和测试治疗策略。
Dopamine neuron dysfunction and loss in the PrknR275W mouse model of juvenile parkinsonism.
Mutations in the PRKN gene encoding the protein parkin cause autosomal recessive juvenile parkinsonism (ARJP). Harnessing this mutation to create an early-onset Parkinson's disease mouse model would provide a unique opportunity to clarify the mechanisms involved in the neurodegenerative process and lay the groundwork for the development of neuroprotective strategies. To this end, we created a knock-in mouse carrying the homozygous PrknR275W mutation, which is the missense mutation with the highest allelic frequency in PRKN patients. We evaluated the anatomical and functional integrity of the nigrostriatal dopamine (DA) pathway, as well as motor behaviour in PrknR275W mice of both sexes. We report here that PrknR275W mice show early DA neuron dysfunction, age-dependent loss of DA neurons in the substantia nigra, decreased DA content and stimulus-evoked DA release in the striatum, and progressive motor impairment. Together, these data show that the PrknR275W mouse recapitulates key features of ARJP. Thus, these studies fill a critical need in the field by introducing a promising new Parkinson's disease model in which to study causative mechanisms of the disease and test therapeutic strategies.
期刊介绍:
Brain, a journal focused on clinical neurology and translational neuroscience, has been publishing landmark papers since 1878. The journal aims to expand its scope by including studies that shed light on disease mechanisms and conducting innovative clinical trials for brain disorders. With a wide range of topics covered, the Editorial Board represents the international readership and diverse coverage of the journal. Accepted articles are promptly posted online, typically within a few weeks of acceptance. As of 2022, Brain holds an impressive impact factor of 14.5, according to the Journal Citation Reports.